A Novel Oral GnRH Antagonist for Managing Endometriosis Pain

Robert L. Barbieri
In: Journal watch · 2017 · vol. 2017 · doi:10.1056/nejm-jw.na44187 · W2620688803
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-27 ⓘ

This study evaluated the efficacy and safety of a novel oral GnRH antagonist for managing pain in women with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis affects 5% to 10% of reproductive-aged women and is a common cause of moderate-to-severe dysmenorrhea and pelvic pain. To evaluate the

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK